Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 870353 | ISIN: US8523123052 | Ticker-Symbol: SR3
Tradegate
25.04.24
16:54 Uhr
42,750 Euro
-1,930
-4,32 %
1-Jahres-Chart
STAAR SURGICAL COMPANY Chart 1 Jahr
5-Tage-Chart
STAAR SURGICAL COMPANY 5-Tage-Chart
RealtimeGeldBriefZeit
43,63043,81021:01
43,63043,81021:01

Aktuelle News zur STAAR SURGICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
05.04.What's going on with STAAR Surgical shares?4
04.04.Eye Lens Maker STAAR Surgical Expects Q1 Sales To Beat Consensus 5
04.04.Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session4
04.04.In-Depth Examination Of 4 Analyst Recommendations For Staar Surgical1
04.04.Staar Surgical, A Lasik Rival, Just Crushed Quarterly Views; But Is Its 2026 Target Too Aggressive?3
04.04.STAAR Surgical up on upbeat preliminary Q1 sales2
04.04.STAAR Surgical expects robust net sales in FY24; shares rise2
04.04.STAAR Surgical Announces Preliminary Net Sales for First Quarter 202495LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL) for myopia...
► Artikel lesen
04.04.STAAR SURGICAL CO - 8-K, Current Report1
14.03.Staar Surgical director Aimee Weisner buys $66.7k in shares1
12.03.STAAR SURGICAL CO - 8-K, Current Report2
11.03.Stifel upgrades STAAR Surgical to Buy, after share price pullback5
28.02.Earnings call: STAAR Surgical reports robust Q4 and FY 2023 results6
27.02.STAAR SURGICAL CO - 10-K, Annual Report4
27.02.STAAR Surgical Co reports results for the quarter ended in December - Earnings Summary5
26.02.STAAR Surgical Company Q4 Income Rises323WASHINGTON (dpa-AFX) - STAAR Surgical Company (STAA) announced a profit for its fourth quarter that increased from the same period last yearThe company's bottom line totaled $7.76 million, or...
► Artikel lesen
26.02.STAAR SURGICAL CO - 8-K, Current Report4
26.02.STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results75LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL) for myopia...
► Artikel lesen
23.01.STAAR Surgical, SharpeVision Partner To Offer EVO ICL Lenses376WASHINGTON (dpa-AFX) - STAAR Surgical Company (STAA) Tuesday announced partnership with ophthalmology group, SharpeVision to provide EVO ICL lenses to all qualified patients in SharpeVision...
► Artikel lesen
23.01.STAAR Surgical collaborates with SharpeVision in the U.S.4
Seite:  Weiter >>
44 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1